Protection of the liver during hepatic surgery

被引:73
作者
Clavien, PA
Emond, J
Vauthey, JN
Belghiti, J
Chari, RS
Strasberg, SM
机构
[1] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland
[2] Columbia Univ, Coll Phys & Surg, Ctr Liver Dis, New York, NY 10027 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[4] Hop Beaujon, Dept HPB Surg, Paris, France
[5] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA
[6] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA
[7] Washington Univ, Sch Med, Div HPB Surg, St Louis, MO 63130 USA
关键词
hepatoprotection; liver volume; liver function;
D O I
10.1016/j.gassur.2003.12.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Very few areas in medicine have seen as many controversies as the evaluation and treatment of patients with liver diseases. Many novel therapies, often marketed before conclusive demonstration of their efficacy, have been developed to enable selective destruction of liver tumors to minimize the risk of liver failure associated with major surgery. Whether these techniques are effective and result in lesser complications often remains speculative. Persisting challenges in selecting the optimal therapy are the evaluation of the risk of surgery in patients with normal or diseased liver and the preparation for surgery. A panel of hepato-biliary surgeons experienced in the management of complex cases convened at the annual meeting of the American Hepato-Pancreato-Biliary Association in Boston, MA, to address the rapidly evolving field of protective strategies for hepatic surgery. (C) 2004 The Society for Surgery of the Alimentary Tract.
引用
收藏
页码:313 / 327
页数:15
相关论文
共 132 条
[1]   Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization [J].
Abdalla, EK ;
Barnett, CC ;
Doherty, D ;
Curley, SA ;
Vauthey, JN .
ARCHIVES OF SURGERY, 2002, 137 (06) :675-680
[2]   Portal vein embolization: rationale, technique and future prospects [J].
Abdalla, EK ;
Hicks, ME ;
Vauthey, JN .
BRITISH JOURNAL OF SURGERY, 2001, 88 (02) :165-175
[3]   TUMOR-NECROSIS-FACTOR INDUCED OXIDATIVE STRESS IN ISOLATED MOUSE HEPATOCYTES [J].
ADAMSON, GM ;
BILLINGS, RE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 294 (01) :223-229
[4]   The isolated perfused porcine liver: Assessment of viability during and after six hours of perfusion [J].
Adham, M ;
Peyrol, S ;
Chevallier, M ;
Ducerf, C ;
Vernet, M ;
Barakat, C ;
DeLaRoche, E ;
Taibi, A ;
Bizollon, T ;
Rigal, D ;
Pouyet, M ;
Baulieux, J .
TRANSPLANT INTERNATIONAL, 1997, 10 (04) :299-311
[5]   Nonsurgical treatment of hepatocellular carcinoma [J].
Aguayo, A ;
Patt, YZ .
SEMINARS IN ONCOLOGY, 2001, 28 (05) :503-513
[6]   Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury [J].
Amersi, F ;
Buelow, R ;
Kato, H ;
Ke, BB ;
Coito, AJ ;
Shen, XD ;
Zhao, DL ;
Zaky, J ;
Melinek, J ;
Lassman, CR ;
Kolls, JK ;
Alam, J ;
Ritter, T ;
Volk, HD ;
Farmer, DG ;
Ghobrial, RM ;
Busuttil, RW ;
Kupiec-Weglinski, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (11) :1631-1639
[7]  
ARORA A, 1996, AM J PHYSIOL, V33, pG238
[8]   Percutaneous acetic acid injection for hepatocellular carcinoma:: Using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent [J].
Arrivé, L ;
Rosmorduc, O ;
Dahan, H ;
Fartoux, L ;
Monnier-Cholley, L ;
Lewin, M ;
Poupon, R ;
Tubiana, JM .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (01) :159-162
[9]   Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization [J].
Azoulay, D ;
Castaing, D ;
Smail, A ;
Adam, R ;
Cailliez, V ;
Laurent, A ;
Lemoine, A ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 231 (04) :480-486
[10]   Continuous versus intermittent portal triad clamping for liver resection -: A controlled study [J].
Belghiti, J ;
Noun, R ;
Malafosse, R ;
Jagot, P ;
Sauvanet, A ;
Pierangeli, F ;
Marty, J ;
Farges, O .
ANNALS OF SURGERY, 1999, 229 (03) :369-375